The goal of the study reported here was to use RNA-seq to identify alterations in mRNA target transcript levels in the same representative ERα-positive and TNBC breast cancer cell lines after AnAc 24:1n5 treatment. The gene discussed is ESR1; the disease is breast carcinoma.